CHYMFCHYMFOTC
Loading
EBITDA Over TimeContracting
Percentile Rank67
3Y CAGR-22.7%
5Y CAGR+72.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-22.7%/yr
Annual compound
5Y CAGR
+72.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
15.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$201.29M-12.5%
2024$230.16M+409.8%
2023$45.14M-89.6%
2022$435.45M+1350.5%
2021$30.02M+129.0%
2020$13.11M-72.3%
2019$47.38M-